Are you Dr. Richards?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 61 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
910 E Houston St
Ste 100
Tyler, TX 75702Phone+1 903-579-9800Fax+1 903-592-5988- Is this information wrong?
Summary
- Dr. Donald Richards, MD is an oncologist in Tyler, Texas. He is currently licensed to practice medicine in Texas and Washington. He is affiliated with CHRISTUS Mother Frances Hospital - Tyler.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 1986 - 1988- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1983 - 1986
- The University of Texas Health Science Center at San AntonioClass of 1983
Certifications & Licensure
TX State Medical License 1985 - 2026
WA State Medical License 1988 - 1992- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer Start of enrollment: 2003 May 01
- A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors Start of enrollment: 2011 Mar 01
- A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer Start of enrollment: 2006 Dec 21
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsPerformance of a Cell-Free DNA-Based Multi-cancer Detection Test in Individuals Presenting With Symptoms Suspicious for Cancers.Alan H Bryce, David D Thiel, Michael V Seiden, Donald Richards, Ying Luan, Marie Coignet, Quan Zhang, Nan Zhang, Earl Hubbell, Kathryn N Kurtzman, Eric A Klein> ;JCO Precision Oncology. 2023 Jul 1
- 6 citationsMRTX-500 Phase 2 Trial: Sitravatinib With Nivolumab in Patients With Nonsquamous NSCLC Progressing On or After Checkpoint Inhibitor Therapy or Chemotherapy.Kai He, David Berz, Shirish M Gadgeel, Wade T Iams, Debora S Bruno, Collin M Blakely, Alexander I Spira, Manish R Patel, David M Waterhouse, Donald A Richards, Anthony...> ;Journal of Thoracic Oncology. 2023 Jul 1
- 60 citationsEvaluation of cell-free DNA approaches for multi-cancer early detection.Arash Jamshidi, Minetta C Liu, Eric A Klein, Oliver Venn, Earl Hubbell, John F Beausang, Samuel Gross, Collin Melton, Alexander P Fields, Qinwen Liu, Nan Zhang, Eric T...> ;Cancer Cell. 2022 Dec 12
- Join now to see all
Press Mentions
Tyler Cancer Center Treating Patients While Maintaining Safe EnvironmentApril 23rd, 2020
POLO Trial Underscores Need for Screening in Metastatic Pancreatic CancerOctober 1st, 2019
Oncologists from the US Oncology Network and US Oncology Research to Present Data from More Than 40 Abstracts During the 54May 30th, 2018- Join now to see all
Hospital Affiliations
CHRISTUS Mother Frances Hospital - TylerTyler, Texas
